CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $332 | -99.9% | 390,000 | -25.3% | 0.52% | -4.0% |
Q3 2022 | $427,000 | -6.4% | 522,009 | +13.5% | 0.55% | +1.3% |
Q2 2022 | $456,000 | -3.4% | 460,103 | +60.0% | 0.54% | -27.5% |
Q1 2022 | $472,000 | +1.5% | 287,500 | +49.0% | 0.74% | +24.4% |
Q4 2021 | $465,000 | -51.0% | 192,909 | -1.7% | 0.60% | -53.2% |
Q3 2021 | $949,000 | +34.6% | 196,168 | -25.7% | 1.28% | +32.0% |
Q2 2021 | $705,000 | -8.1% | 263,975 | +6.0% | 0.97% | +11.8% |
Q1 2021 | $767,000 | +14.0% | 249,006 | +31.7% | 0.87% | -23.7% |
Q4 2020 | $673,000 | +77.6% | 189,081 | +86.8% | 1.14% | +288.1% |
Q2 2019 | $379,000 | -37.3% | 101,218 | -32.6% | 0.29% | -4.6% |
Q1 2019 | $604,000 | +21.8% | 150,199 | +11.2% | 0.31% | -2.8% |
Q4 2018 | $496,000 | +15.3% | 135,123 | +400.5% | 0.32% | +105.2% |
Q3 2017 | $430,000 | – | 27,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |